Sandra Milligan - Feb 28, 2023 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of Research & Development
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Sandra Milligan
Stock symbol
OGN
Transactions as of
Feb 28, 2023
Transactions value $
-$58,861
Form type
4
Date filed
3/2/2023, 04:29 PM
Previous filing
Jul 15, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise +7.98K +52.37% 23.2K Feb 28, 2023 Direct F1
transaction OGN Common Stock Tax liability -$58.9K -2.35K -10.11% $25.09 20.9K Feb 28, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -7.98K -100% $0.00* 0 Feb 28, 2023 Common Stock 7.98K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. common stock.
F2 As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023.
F3 The amount of Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations.